Truemeds was founded to bridge India’s medicine price gap by offering doctor-guided, affordable alternatives for chronic care patients.
Truemeds
The idea behind Truemeds emerged from a simple but persistent issue in India’s pharmaceutical market: patients often pay very different prices for medicines that are chemically identical. This gap is most visible among people managing chronic conditions, who take medicines over long periods and face recurring monthly expenses. The founders of Truemeds observed that in many cases, higher costs were linked more to branding, promotions and marketing costs than to differences in formulation or quality.
Truemeds was founded by Akshat Nayyar and Dr. Kunal Wani, who approached the problem from complementary perspectives spanning healthcare operations and clinical practice. Through their early interactions with patients and prescriptions, they noted that while multiple approved brands existed for the same medicine, patients were rarely informed about these alternatives. Even when lower-priced options were available, hesitation around switching was common, largely due to concerns about effectiveness and a lack of medical guidance.
In the early stages, the founders spent time studying prescription trends and patient behaviour, particularly among those undergoing long-term treatment. Their findings pointed to a trust gap rather than a supply gap. Patients were wary of alternatives not because they were unavailable, but because of lack of awareness about generic medicine altogether. This insight shaped the decision to build a platform that combined medicine ordering with structured medical consultation.
Truemeds was launched as a digital healthcare platform focused on chronic care medicines. Instead of operating purely as an online pharmacy, the company built processes around prescription checks, consultation-led communication, and informed substitution. The intent was to ensure that users understood their medicine options before placing an order, rather than encountering changes at the point of delivery.
As the platform developed, the founders focused on putting systems in place to support compliance and consistency, alongside technology to manage scale. This included setting internal standards for prescription review, substitution approval, and sourcing practices. Over time, these choices placed Truemeds within a growing group of Indian healthtech companies attempting to balance digital convenience with medical oversight.
The formation of Truemeds reflects a broader shift in healthcare entrepreneurship toward addressing long-standing inefficiencies through technology, particularly in areas where cost sensitivity and long-term treatment intersect. By focusing on chronic patients and off-patent medicines, the founders positioned the company within a segment of the healthcare market where transparency and affordability continue to be central concerns.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
